Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.97 - $5.2 $250,676 - $438,895
-84,403 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.99 - $7.46 $421,170 - $629,646
84,403 New
84,403 $421,000
Q4 2020

Feb 08, 2021

SELL
$8.5 - $12.85 $472,600 - $714,460
-55,600 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$9.57 - $27.05 $532,092 - $1.5 Million
55,600 New
55,600 $645,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $489M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.